Refractory Acute Myelogenous Leukemia
2 clinical trials · Condition
◉ Watch Refractory Acute Myelogenous Leukemia
| Record | Firm | Date |
|---|---|---|
| Open Label NK Cell Infusion (FATE-NK100) With Subq IL-2 in Adults With AML (NCT03081780) | Masonic Cancer Center, University of Minnesota | 2017-04-27 |
| T-Cell Depleted Double UCB for Refractory AML (NCT01464359) | Masonic Cancer Center, University of Minnesota | 2011-10-01 |
Track Refractory Acute Myelogenous Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.